These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22629463)

  • 1. Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.
    Rathore SS; Agarwal SK; Pande S; Singh SK; Mittal T; Mittal B
    PLoS One; 2012; 7(5):e37844. PubMed ID: 22629463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An acenocoumarol dosing algorithm exploiting clinical and genetic factors in South Indian (Dravidian) population.
    Krishna Kumar D; Shewade DG; Loriot MA; Beaune P; Sai Chandran BV; Balachander J; Adithan C
    Eur J Clin Pharmacol; 2015 Feb; 71(2):173-81. PubMed ID: 25519826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP4F2 1347 G > A & GGCX 12970 C > G polymorphisms: frequency in north Indians & their effect on dosing of acenocoumarol oral anticoagulant.
    Rathore SS; Agarwal SK; Pande S; Singh SK; Mittal T; Mittal B
    Indian J Med Res; 2014 Apr; 139(4):572-8. PubMed ID: 24927344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysis.
    Ragia G; Karantza IM; Kelli-Kota E; Kolovou V; Kolovou G; Konstantinides S; Maltezos E; Tavridou A; Tziakas D; Maitland-van der Zee AH; Manolopoulos VG
    Drug Metab Pers Ther; 2017 Dec; 32(4):183-190. PubMed ID: 29252193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a genotype-based dosing algorithm for acenocoumarol steady dose.
    Cerezo-Manchado JJ; Rosafalco M; Antón AI; Pérez-Andreu V; Garcia-Barberá N; Martinez AB; Corral J; Vicente V; González-Conejero R; Roldán V
    Thromb Haemost; 2013 Jan; 109(1):146-53. PubMed ID: 23196355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients.
    Elkhazraji A; Bouaiti EA; Boulahyaoui H; Nahmtchougli CP; Zahid H; Bensaid M; Ibrahimi A; Messaoudi N
    Drug Discov Ther; 2018; 12(2):68-76. PubMed ID: 29760340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study.
    Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; le Cessie S; Swen JJ; van der Straaten T; de Boer A; Maitland-van der Zee AH
    J Thromb Haemost; 2018 Sep; 16(9):1732-1742. PubMed ID: 29935043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes.
    Baranova EV; Verhoef TI; Ragia G; le Cessie S; Asselbergs FW; de Boer A; Manolopoulos VG; Maitland-van der Zee AH;
    J Thromb Haemost; 2017 Mar; 15(3):465-472. PubMed ID: 28063245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.
    Jiménez-Varo E; Cañadas-Garre M; Gutiérrez-Pimentel MJ; Calleja-Hernández MA
    Pharmacogenet Genomics; 2014 Oct; 24(10):501-13. PubMed ID: 25089947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acenocoumarol Pharmacogenetic Dosing Algorithms and Their Application in Two Bulgarian Patients with Low Anticoagulant Requirements.
    Dimitrova-Karamfilova A; Tzveova R; Chilingirova N; Goranova T; Nachev G; Mitev V; Kaneva R
    Biochem Genet; 2015 Dec; 53(11-12):334-50. PubMed ID: 26377995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.
    Tong HY; Dávila-Fajardo CL; Borobia AM; Martínez-González LJ; Lubomirov R; Perea León LM; Blanco Bañares MJ; Díaz-Villamarín X; Fernández-Capitán C; Cabeza Barrera J; Carcas AJ;
    PLoS One; 2016; 11(3):e0150456. PubMed ID: 26977927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.
    Carcas AJ; Borobia AM; Velasco M; Abad-Santos F; Díaz MQ; Fernández-Capitán C; Ruiz-Giménez N; Madridano O; Sillero PL;
    Trials; 2012 Dec; 13():239. PubMed ID: 23237631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of acenocoumarol in patients with extreme dose requirements.
    Pérez-Andreu V; Roldán V; López-Fernández MF; Antón AI; Alberca I; Corral J; Montes R; García-Barberá N; Ferrando F; Vicente V; González-Conejero R
    J Thromb Haemost; 2010 May; 8(5):1012-7. PubMed ID: 20149073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease.
    Borobia AM; Lubomirov R; Ramírez E; Lorenzo A; Campos A; Muñoz-Romo R; Fernández-Capitán C; Frías J; Carcas AJ
    PLoS One; 2012; 7(7):e41360. PubMed ID: 22911785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic and clinical factors on dose requirements and quality of anticoagulation therapy in Polish patients receiving acenocoumarol: dosing calculation algorithm.
    Wolkanin-Bartnik J; Pogorzelska H; Szperl M; Bartnik A; Koziarek J; Bilinska ZT
    Pharmacogenet Genomics; 2013 Nov; 23(11):611-8. PubMed ID: 24108193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapolation of acenocoumarol pharmacogenetic algorithms.
    Jiménez-Varo E; Cañadas-Garre M; Garcés-Robles V; Gutiérrez-Pimentel MJ; Calleja-Hernández MÁ
    Vascul Pharmacol; 2015 Nov; 74():151-157. PubMed ID: 26122664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial.
    Ragia G; Kolovou V; Kolovou G; Konstantinides S; Maltezos E; Tavridou A; Tziakas D; Maitland-van der Zee AH; Manolopoulos VG
    Pharmacogenomics; 2017 Jan; 18(1):23-34. PubMed ID: 27967328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
    Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
    Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.
    van Schie RM; Wessels JA; le Cessie S; de Boer A; Schalekamp T; van der Meer FJ; Verhoef TI; van Meegen E; Rosendaal FR; Maitland-van der Zee AH;
    Eur Heart J; 2011 Aug; 32(15):1909-17. PubMed ID: 21636598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants of acenocoumarol and warfarin maintenance dose requirements in Slavic population: a potential role of CYP4F2 and GGCX polymorphisms.
    Wypasek E; Branicka A; Awsiuk M; Sadowski J; Undas A
    Thromb Res; 2014 Sep; 134(3):604-9. PubMed ID: 25042728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.